Accendra Health Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.1 | 0.1 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.4 | 0.7 | 0.7 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.3 | 8.2 | 8.6 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -148.9% | -112.2% | -85.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 12.2% | 12.2% | 12.2% | 12.2% | 12.4% | 12.6% | 13.0% | 13.3% | 13.6% | 14.5% | 14.0% | 13.7% | 13.2% | 12.3% | 12.5% | 13.1% | 14.0% | 15.1% | 16.8% | 16.9% | 16.2% | 15.5% | 14.6% | 16.0% | 17.8% | 18.3% | 19.4% | 19.1% | 19.2% | 20.6% | 20.8% | 23.0% | 26.5% | 26.5% | 26.3% | 26.3% | 26.1% | 31.7% | 46.0% | 44.8% | |
| 2.1% | 2.1% | 2.0% | 1.8% | 1.6% | 1.0% | 0.8% | -1.3% | -1.4% | -3.7% | -3.8% | -1.8% | -1.8% | 0.8% | 0.7% | 0.9% | 1.5% | 2.4% | 3.9% | 4.4% | 4.2% | 3.8% | 2.9% | 2.6% | 2.6% | 1.4% | 0.9% | 0.3% | -0.1% | 1.0% | 1.0% | 1.3% | 1.8% | -3.1% | -3.2% | -2.6% | -2.2% | 3.5% | 6.9% | 3.6% | |
| 1.2% | 1.1% | 1.1% | 1.0% | 0.8% | 0.8% | 0.7% | -1.5% | -1.6% | -4.6% | -4.9% | -3.1% | -3.1% | -0.7% | -0.7% | -1.2% | -0.7% | 0.4% | 1.3% | 2.5% | 2.4% | 2.3% | 1.9% | 1.6% | 1.2% | 0.2% | -0.4% | -1.0% | -1.1% | -0.4% | -0.4% | -0.5% | -0.7% | -5.4% | -5.5% | -18.0% | -20.0% | -23.3% | -39.8% | -11.4% | |
| 1.9% | 1.6% | 0.8% | 0.2% | 0.0% | 0.1% | 0.5% | 1.4% | 1.2% | 0.5% | -0.3% | 0.4% | 0.8% | 1.2% | 3.1% | 3.0% | 3.1% | 3.2% | 2.4% | 1.4% | 0.8% | 0.8% | 1.3% | 1.9% | 1.6% | 1.6% | 2.0% | 4.2% | 5.0% | 5.2% | 3.1% | 1.5% | -0.2% | -0.9% | -0.8% | -2.6% | -5.5% | -6.8% | -7.3% | -8.4% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| 11.5% | 11.3% | 10.7% | 9.6% | 7.7% | 7.2% | 6.1% | -17.5% | -19.2% | -84.3% | -91.5% | -57.7% | -58.0% | -13.5% | -14.3% | -26.5% | -13.3% | 4.2% | 14.1% | 27.4% | 26.0% | 23.6% | 20.2% | 16.1% | 12.7% | 2.4% | -4.5% | -11.0% | -13.2% | -4.5% | -4.3% | -4.9% | -5.6% | -64.2% | -64.1% | – | – | – | – | – | |
| 4.1% | 4.0% | 3.8% | 3.4% | 2.3% | 2.2% | 1.8% | -3.5% | -3.8% | -11.6% | -11.8% | -7.4% | -7.7% | -1.7% | -1.6% | -3.3% | -1.8% | 0.9% | 3.3% | 6.5% | 6.4% | 6.3% | 3.4% | 2.8% | 2.2% | 0.4% | -0.8% | -1.9% | -2.3% | -0.8% | -0.7% | -0.8% | -1.0% | -7.8% | -7.5% | -29.0% | -33.2% | -44.9% | -44.8% | -14.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | -75 | -28 | 12 | -2.7 | 16 | – | – | – | -84 | -53 | -44 | -38 | -12 | -142 | 15 | -1.3 | 25 | -46 | -175 | -98 | 50 | -27 | -41 | 1,845 | 1,800 | 1,881 | 1,983 | 2,082 | 1,811 | 1,766 | 1,710 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.1 | – | – | – | -0.3 | -0.1 | -0.1 | -0.1 | 0.0 | -0.4 | 0.0 | 0.0 | 0.1 | -0.1 | -0.6 | -0.3 | 0.1 | -0.1 | -0.1 | 4.5 | 32.5 | 57.4 | – | – | 8.3 | 7.5 | 7.4 | |
| 35.3% | 35.3% | 35.9% | 35.5% | 30.1% | 30.1% | 30.0% | 19.8% | 19.7% | 13.7% | 12.9% | 12.8% | 13.3% | 12.7% | 11.2% | 12.6% | 13.7% | 21.3% | 23.2% | 23.6% | 24.7% | 26.5% | 16.6% | 17.3% | 17.5% | 17.6% | 17.4% | 16.9% | 17.3% | 18.1% | 17.2% | 16.2% | 17.2% | 12.1% | 11.8% | -6.8% | -10.6% | -18.8% | -19.2% | -26.1% | |
| – | – | – | – | – | – | – | – | – | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.3 | 0.2 | 0.3 | 2.2 | 3.3 | 3.4 | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| 1.86 | 1.81 | 1.72 | 1.60 | 1.28 | 1.21 | 1.04 | -2.36 | -2.55 | -7.29 | -7.61 | -4.80 | -4.75 | -1.04 | -0.98 | -1.71 | -0.98 | 0.43 | 1.56 | 3.06 | 3.03 | 2.92 | 2.52 | 2.02 | 1.60 | 0.30 | -0.55 | -1.29 | -1.54 | -0.53 | -0.51 | -0.55 | -0.63 | -4.70 | -4.73 | -15.64 | -17.34 | -14.35 | -14.11 | -3.94 | |
| 161.32 | 161.36 | 159.90 | 156.67 | 155.34 | 155.38 | 156.12 | 159.91 | 162.06 | 157.04 | 155.63 | 155.75 | 152.30 | 153.29 | 148.30 | 137.64 | 136.38 | 120.95 | 122.42 | 123.55 | 127.44 | 128.76 | 129.78 | 129.45 | 129.18 | 132.76 | 133.97 | 133.70 | 134.23 | 132.87 | 136.58 | 111.06 | 85.82 | 86.25 | 86.39 | 87.05 | 86.78 | 61.54 | 35.41 | 34.51 | |
| 16.17 | 15.93 | 16.16 | 16.60 | 16.77 | 16.93 | 16.99 | 13.43 | 13.26 | 8.64 | 8.31 | 8.31 | 8.18 | 7.69 | 6.87 | 6.46 | 7.41 | 10.16 | 11.08 | 11.19 | 11.68 | 12.35 | 12.47 | 12.56 | 12.65 | 12.61 | 12.30 | 11.82 | 11.64 | 11.88 | 11.73 | 11.22 | 11.35 | 7.32 | 7.39 | -3.65 | -5.56 | -6.01 | -6.06 | -7.18 | |
| 2.99 | 2.60 | 1.30 | 0.35 | 0.03 | 0.10 | 0.86 | 2.16 | 1.90 | 0.83 | -0.49 | 0.62 | 1.26 | 1.89 | 4.57 | 4.07 | 4.18 | 3.90 | 2.89 | 1.70 | 0.96 | 0.98 | 1.64 | 2.42 | 2.04 | 2.11 | 2.62 | 5.61 | 6.73 | 6.85 | 4.24 | 1.70 | -0.14 | -0.75 | -0.72 | -2.27 | -4.79 | -4.17 | -2.58 | -2.91 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.